Abstract
Purpose. Using monolayers of human pancreatic adenocarcinoma cells (Panc-1) that express multidrug resistance-associated protein (MRP), the present work investigates the effects of Pluronic block copolymers on the functional activity of MRP.
Methods. The studies examined the accumulation and efflux of the MRP selective probe fluorescein (FLU) in Panc-1 cell monolayers with and without Pluronic P85 (P85), Pluronic L81 (L81) and Pluronic F108 (F108).
Results. Treatment of Panc-1 cells with P85 resulted in concentration-dependent increases in FLU accumulation and elimination of FLU sequestration in vesicular compartments in these cells. The effects of P85 were selective for FLU in the Panc-1 cell monolayers. Inhibition of MRP-mediated transport was dependent on the composition of Pluronic block copolymer: the more hydrophobic copolymer had the greater effect on FLU uptake in Panc-1 monolayers (L81 > P85 > F108).
Conclusions. This paper demonstrates for the first time that Pluronic block copolymers inhibit multidrug resistance-associated protein (MRP). The similarities in the effects of Pluronic block copolymers on MRP and P-glycoprotein drug efflux systems suggest that a single unifying mechanism may explain the inhibition observed.
Similar content being viewed by others
REFERENCES
A. Krishan, C. M. Fitz, and I. Andritsch. Drug retention, efflux, and resistance in tumor cells. Cytometry 29:279-285 (1997).
H. W. Van Veen and W. N. Konings. Multidrug transport from bacteria to man: similarities in structure and function. Semin. Cancer Biol. 8:183-191 (1997).
P. G. Bray and S. A. Ward. A comparison of the phenomenology and genetics of multidrug resistance in cancer cells and quinoline resistance in plasmodium falciparum. Pharmacol. Ther. 77:1-28 (1998).
U. A. Germann, I. Pastan, and M. M. Gottesman. p-Glycoproteins: mediators of multidrug resistance. Semin. Cell. Biol. 4:63-76 (1993).
A. H. Schinkel, J. J. M. Smit, O. van Tellingen, J. H. Beijnen, E. Wagenaar, L. van Deemter, C. A. A. M. Mol, M. A. van der Valk, E. C. Robanus-Maandag, H. P. J. te Riele, A. J. M. Berns, and P. Borst. Disruption of the mouse mdr-1 a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77:491-502 (1994).
V. Y. Alakhov, E. Y. Moskaleva, E. V. Batrakova, and A. V. Kabanov. Hypersensitization of multidrug resistant human ovarian carcinoma cells by pluronic P85 block copolymer. Bioconjugate Chem. 7:209-216 (1996).
A. Venne, S. Li, R. Mandeville, A. V. Kabanov, and V. Y. Alakhov. Hypersensitizing effect of pluronic L61 on cytotoxic activity, transport and subcellular distribution of doxorubicin in multiple drug-resistant cells. Cancer Res. 56:3626-3629 (1996).
D. W. Miller, E. V. Batrakova, T. O. Waltner, V. Y. Alakhov, and A. V. Kabanov. Interactions of Pluronic block copolymers with brain microvessel endothelial cells: evidence of two potential pathways for drug absorption. Bioconjugate Chem. 8:649-657 (1997).
M. A. Barrand, T. Bagrij, and S. Y. Neo. Multidrug resistance-associated protein: a protein disinct from P-glycoprotein involved in cytotoxic drug expulsion. Gen. Pharmacol. 28:639-645 (1997).
Z. Hollo, L. Homolya, T. Hegedus, and B. Sarkadi. Transport properties of the multidrug resistance-associated protein (MRP) in human tumor cells. FEBS Lett. 383, 99-104 (1996).
G. Jedlitschky, I. Leier, U. Buchholz, K. Barnouin, G. Kurz, and D. Keppler. Transport of glutatione, glucuronate, and sulfate conjugates by the MRP gene-encoded export pump. Cancer Res. 56:988-994 (1996).
M. J. Flens, G. J. Zaman, P. van-der-Valk, M. A. Izquierdo, A. B. Schroeijers, G. L. Scheffer, P. van-der-Groep, M. de-Haas, C. J. Meijer, R. J. Scheper. Tissue distribution of the multidrug resistance protein. Am. J. Pathol. 148:1237-1247 (1996).
D. W. Miller, M. Fontaine, C. Kolar, T. Lawson. The expression of multidrug resistance-associated protein (MRP) in pancreatic adenocarcinoma cell lines. Cancer Lett. 107:301-306 (1996).
H. Huai-Yun, D. T. Secrest, K. S. Mark, D. Carney, C. Brandquist, W. F. Elmquist, and D. W. Miller. Expression of multidrug resistance-associated protein (MRP) in brain microvessel endothelial cells. Biochem. Biophys. Res. Com. 243: 816-820 (1998).
M. P. Draper, R. L. Martell, and S. B. Levy. Indomethacin-mediated reversal of multidrug resistance and drug efflux in human and murine cell lines overexpressing MRP, but not P-glycoprotein. Br. J. Cancer 75:810-815 (1997).
M. Fontaine, W. F. Elmquist, and D. W. Miller. Use of rhodamine 123 to examine the functional activity of P-glycoprotein in primary cultured brain microvessel endothelial cell monolayers. Life Sci. 59:1521-1531 (1996).
E. V. Batrakova, H.-Y. Han, V. Yu. Alakhov, D. W. Miller, and A. V. Kabanov. Effects of Pluronic block copolymers on drug absorption in Caco-2 cell monolayers. Pharm. Res. 15:850-855 (1998).
K. Nooter and G. Stoter. Molecular mechanisms of multidrug resistance in cancer chemotherapy. Pathol. Res. Pract. 192:768-780 (1996).
L. M. Breuninger, S. Paul, K. Gaughan, T. Miki, A. Chan, S. A. Aaronson, and G. D. Kruh. Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution. Cancer. Res. 55:5342-5347 (1995).
I. Cleary, G. Doherty, E. Moran, and M. Clynes. The multidrug-resistant human lung tumour cell line, DLKP-A10, expresses novel drug accumulation and sequestration systems. Biochem. Pharmacol. 53:1493-1502 (1997).
P. R. Twentyman. Transport proteins in drug resistance: biology and approaches to circumvention. J. Intern. Med. Suppl. 740:133-137 (1997).
A. B. Shapiro, K. Fox, P. Lee, Y. D. Yang, and V. F. Ling. Functional intracellular P-glycoprotein. Int. J. Cancer 76:857-864 (1998).
Y. Abe, Y. Ohnishi, M. Yoshimura, E. Ota, Y. Ozeki, Y. Oshika, T. Tokunaga, H. Yamazaki, Y. Ueyema, T. Ogata, N. Tamaoki, and M. Nakamura. P-Glycoprotein-mediated acquired multidrug resistance of human lung cancer cells in vivo. Br. J. Cancer 74:1929-1934 (1996).
G. D. Kruh, K. T. Gaughan, A. Godwin, and A. Chan. Expression pattern of MRP in human tissues and adult solid tumor cell lines. J. Natl. Cancer Inst. 87:1256-1258 (1995).
M. J. Flens, G. J. Zaman, P. van der Valk, M. A. Izquierdo, A. B. Schroeijers, G. L. Scheffer, P. van der Groep, M. de Haas, C. J. Meijer, and R. J. Scheper. Tissue distribution of the multidrug resistance protein. Am. J. Phathol. 148:1237-1247 (1996).
B. D. Stride, G. Valdimarsson, J. H. Gerlach, G. M. Wilson, S. P. Cole, and R. G. Deeley. Structure and expression of the messenger RNA encoding the murine multidrug resistance protein, an ATP-binding cassette transporter. Mol. Pharmacol. 49:962-971 (1996).
E. V. Batrakova, T. Yu. Dorodnych, E. Yu. Klinskii, E. N. Kliushnenkova, O. B. Shemchukova, S. A. Arjakov, V. Yu. Alakhov, A. V. Kabanov. Anthracycline antibiotics non-covalently incorporated into the block-copolymer micelles: in vivo evaluation of anticancer activity. Br. J. Cancer 74:1545-1552 (1996).
V. Yu. Alakhov, A. V. Kabanov. Block copolymeric biotransport carriers as versatile vehicles for drug delivery. Expert Op. Invest. Drugs 7:1453-1473 (1998).
E. V. Batrakova, H-Y. Han, D. W. Miller, A. V. Kabanov. Effects of Pluronic P85 unimers and micelles on drug permeability in polarized BBMEC and Caco-2 cells. Pharm. Res. 15:1525-1532 (1998).
R. B. Kim, M. F. Fromm, C. Wandel, B. Leake, A. J. J. Wood, D. M. Roden, and G. R. Wilkinson. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J. Clin. Invest. 101:289-294 (1998).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Miller, D.W., Batrakova, E.V. & Kabanov, A.V. Inhibition of Multidrug Resistance-Associated Protein (MRP) Functional Activity with Pluronic Block Copolymers. Pharm Res 16, 396–401 (1999). https://doi.org/10.1023/A:1018873702411
Issue Date:
DOI: https://doi.org/10.1023/A:1018873702411